CREB3 and osteosarcoma: This group concluded that circTADA2A targets an oncogene, CREB3 to promote osteosarcoma progression and metastasis via sponging to miR-203a-3p and emphasized circTADA2A-miR-203a-3p-CREB3 axis as a potent osteosarcoma-targeted therapy.